Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Truist Financial Analyst Says

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target raised by investment analysts at Truist Financial from $21.00 to $22.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective points to a potential upside of 5.95% from the stock’s current price.

SBRA has been the topic of a number of other research reports. Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Citigroup raised their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Jefferies Financial Group restated a “buy” rating and set a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Finally, UBS Group boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, February 19th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $21.90.

Sabra Healthcare REIT Trading Down 0.1%

SBRA stock traded down $0.02 during midday trading on Friday, hitting $20.77. 1,067,699 shares of the company’s stock were exchanged, compared to its average volume of 2,781,832. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29. The company has a market cap of $5.24 billion, a PE ratio of 32.48, a price-to-earnings-growth ratio of 1.66 and a beta of 0.64. Sabra Healthcare REIT has a one year low of $15.75 and a one year high of $21.07. The stock’s fifty day moving average price is $19.62 and its 200-day moving average price is $19.00.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same period in the prior year, the firm earned $0.36 earnings per share. The firm’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of large investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. grew its holdings in Sabra Healthcare REIT by 2.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after buying an additional 528 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares in the last quarter. Anchor Investment Management LLC raised its stake in Sabra Healthcare REIT by 15.5% in the 3rd quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock worth $77,000 after purchasing an additional 556 shares in the last quarter. Inspire Investing LLC boosted its holdings in Sabra Healthcare REIT by 2.3% in the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock valued at $469,000 after purchasing an additional 565 shares during the period. Finally, Oppenheimer & Co. Inc. raised its position in shares of Sabra Healthcare REIT by 1.7% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock valued at $633,000 after buying an additional 581 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.